This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cardiovascular Risk Factors
and you are
between 18 and 75
years old
The phase for this study is not defined.
Show me locations

The purpose

The study is designed to compare the effects of two combination of nutraceuticals: Armolipid Plus® and LopiGLIK® (Akademy Pharma), a new supplement that, in addition to Berberine and Red Rice, contains Morus Alba's extract. The study will analyze the impact of 16 week treatment with one of the combinations, according to a randomized scheme, on metabolic parameters in dyslipidemic subjects that do not require or not tolerate a statin therapy. In particular, it will assess the ability of the two combinations to reduce the levels of total and LDL cholesterol, HbA1C, glicaemia and insulin and increase those of HDL cholesterol.

Provided treatments

  • Other: Placebo
  • Other: Prescribed Diet
  • : LopiGLIK®
  • : Armolipid Plus

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02898805. The sponsor of the trial is Federico II University and it is looking for 600 volunteers for the current phase.
Official trial title:
Effects of a New Combination of Nutraceutics (LopiGLIK®) on Cardiovascular Risk